← All trials
NCT00294671
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2006
- Primary completion
- Dec 1, 2012
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 130
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Boston UniversityLead sponsor
- Food and Drug AdministrationCollaborator
- Boston UniversityOverall official - principal investigator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- Boston UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.